Subject(s)
Cardiopulmonary Resuscitation , Heart Arrest , Myocardial Infarction , Death , Hemodynamics , HumansABSTRACT
Primary percutaneous coronary intervention (PCI) is the preferred method of reperfusion in patients with ST-elevation myocardial infarction (STEMI). Therefore, increasing timely access to PCI is a major national focus. The majority of United States hospitals are not PCI capable, which has stimulated the development of regional STEMI programs using standardized protocols and organized transfer systems. These regional STEMI systems have improved treatment times and clinical outcomes, leading to a recent class I recommendation in the American College of Cardiology/American Heart Association guidelines to develop STEMI systems of care. Despite this, less than 15% of patients transferred from non-PCI hospitals to PCI centers have total door-to-balloon times less than 2 hours. We review the therapeutic options for the STEMI patient with expected delay to PCI focusing on recent pharmacoinvasive trials. Based on these trial results, recent guidelines recommend early transfer and cardiac catheterization for patients treated with fibrinolytic therapy.
Subject(s)
Angioplasty, Balloon, Coronary , Health Services Accessibility/organization & administration , Myocardial Infarction/therapy , Outcome and Process Assessment, Health Care/organization & administration , Quality of Health Care/organization & administration , Regional Health Planning/organization & administration , Thrombolytic Therapy , Delivery of Health Care, Integrated/organization & administration , Humans , Myocardial Infarction/mortality , Organizational Innovation , Patient Transfer , Practice Guidelines as Topic , Time Factors , Treatment OutcomeABSTRACT
BACKGROUND: Indications for cardiac implantable electronic devices (CIEDs) are increasing. Although CIED infections occur infrequently, the impact of this outcome is expected to be substantial. OBJECTIVE: The purpose of this study was to the evaluate the outcome of patients undergoing removal of infected CIEDs. METHODS: A retrospective study was conducted of all patients with proven or suspected infected CIEDs who were referred to the Cleveland Clinic for system removal from January 2002 through March 2007. RESULTS: A total of 412 patients (age 68 +/- 15 years) were included in the study. The majority of patients (241 [59%]) presented with localized infection involving the device pocket. The remaining 171 patients (41%) presented with endovascular infection but no evidence of inflammation of the device pocket. Of the total 414 pathogens isolated, 366 (88%) were aerobic gram-positive organisms, of which 90% were Staphylococcus species, and almost half of these were methicillin resistant. In-hospital mortality was 4.6% (19 patients). Only 2 deaths were extraction related. One-year mortality was 17%. Among the total cohort, 8 (1.9%) patients had relapsing infection within the first year. Among patients who had device replacement during the same hospitalization, 6 (2.6%) had relapsing infections within 1 year of reimplantation; 5 of these patients had systemic symptoms and were bacteremic upon initial presentation. CONCLUSION: CIED infections are most often caused by Staphylococcus species, half of which are methicillin resistant. Percutaneous lead and device removal along with antibiotic therapy are effective as primary interventions. The overall relapse rate is 1.9%, and the relapse rate among patients who had reimplantation during the same hospitalization is 2.6%.
Subject(s)
Defibrillators, Implantable/adverse effects , Electrodes, Implanted/adverse effects , Pacemaker, Artificial/adverse effects , Prosthesis-Related Infections/therapy , Staphylococcal Infections/therapy , Aged , Aged, 80 and over , Anti-Bacterial Agents/therapeutic use , Device Removal , Female , Humans , Male , Middle Aged , Prosthesis-Related Infections/diagnosis , Prosthesis-Related Infections/etiology , Retrospective Studies , Staphylococcal Infections/diagnosis , Staphylococcal Infections/etiology , Treatment OutcomeSubject(s)
Cardiac Care Facilities , Cardiac Catheterization/methods , Cardiovascular Diseases/diagnosis , Coronary Angiography/methods , Imaging, Three-Dimensional/methods , Cardiac Catheterization/instrumentation , Coronary Angiography/instrumentation , Humans , Imaging, Three-Dimensional/instrumentationABSTRACT
Left main (LM) coronary disease, carotid artery disease, and peripheral arterial disease each reflects advanced atherosclerosis. The frequency of their coexistence in the same patient has not been fully elucidated. All coronary angiograms obtained at the Cleveland Clinic from November 2003 to October 2005 were analyzed for presence of LM stenosis > or =50%. Patients with previous coronary artery bypass graft surgery were excluded. Patients with available carotid ultrasound and ankle-brachial indexes formed the analysis cohorts. A total of 10,298 coronary angiograms were obtained in 9,715 patients. There were 186 patients with LM disease and 1,913 patients without LM disease with carotid artery ultrasound data. There were 29 patients with LM disease and 604 patients without LM disease with available ankle-brachial indexes. Patients with significant LM disease more frequently had associated carotid stenosis > or =60% compared with patients without LM disease (31.2% vs 15.2%, p <0.0001). Patients with LM disease had lower mean ankle-brachial indexes compared with patients without LM disease (0.78 vs 0.87, p = 0.042). In conclusion, compared with patients without LM disease, patients with LM disease have a higher burden of advanced atherosclerosis as evidenced by a higher prevalence of significant carotid stenosis and lower ankle-brachial indexes.
